We investigated the role of leptin and asymmetric dimethylarginine (ADMA) in uncomplicated hypertension. We also investigated their relationship with insulin resistance and serum levels of several metabolic parameters, including homocysteine, lipoprotein(a) and malondialdehyde (MDA). A total of 34 untreated newly-diagnosed hypertensive patients (seven men and 27 women; mean age, 57.4 ± 10.1 years) and 38 normotensive healthy subjects (20 men and 18 women; mean age, 55.9 ± 8.7 years) were studied prospectively. Serum leptin, homocysteine, lipoprotein(a), MDA and insulin resistance (HOMA-IR) were significantly higher in hypertensive patients compared with normotensive subjects. There were no significant differences in ADMA, insulin-like growth factor-1 and insulin-like growth factor binding protein-3 between the two groups. No correlation was found between serum ADMA and leptin levels. Our findings suggest that high serum leptin and homocysteine levels, oxidative stress and insulin resistance may be important risk factors for atherosclerosis among patients with uncomplicated hypertension.
TakiuchiSFujiiHKamideK: Plasma asymmetric dimethylarginine and coronary and peripheral endothelial dysfunction in hypertensive patients. Am J Hypertens2004; 17: 802–808.
2.
SabuncuTVuralHHarmaM: Oxidative stress in polycystic ovary syndrome and its contribution to the risk of cardiovascular disease. Clin Biochem2001; 34: 407–413.
3.
NapoliCSicaVde NigrisF: Sulfydryl angiotensin-converting enzyme inhibition induces sustained reduction of systemic oxidative stress and improves the nitric oxide pathway in patients with essential hypertension. Am Heart J2004; 148: e5.
4.
SydowKSchwedhelmEArakawaN: ADMA and oxidative stress are responsible for endothelial dysfunction in hyperhomocyst(e)inemia: Effects of l-arginine and B vitamins. Cardiovasc Res2003; 57: 244–252.
5.
StühlingerMCAbasıFChuJW: Relationship between insulin resistance and an endogenous nitric oxide synthase inhibitor. JAMA2002; 287: 1420–1426.
6.
LentzSRRodionovRNDayalS: Hyperhomocysteinemia, endothelial dysfunction, and cardiovascular risk: The potential role of ADMA. Atherosclerosis2003; 4 (suppl): 61–65.
7.
GalderisiMTagliamonteD'ErricoA: Independent association of plasma leptin levels and left ventricular isovolemic relaxation in uncomplicated hypertension. Am J Hypertens2001; 14: 1019–1024.
8.
SuterPMLocherRHaslerE: Is there a role for the ob gene product leptin in essential hypertension. Am J Hypertens1998; 11: 1305–1311.
9.
WatanabeTItokawaMNakagawaY: Increased levels of insulin-like growth factor binding protein-3 in hypertensive patients with carotid atherosclerosis. Am J Hypertens2003; 16: 754–760.
10.
VerdecchiaPReboldiGSchillaciG: Circulating insulin and insulin growth factor-1 are independent determinants of left ventricular mass and geometry in essential hypertension. Circulation1999; 100: 1802–1807.
11.
The Joint National Committee on Detection, Evaluation and Treatment of High Blood Pressure: The Sixth Report of the Joint National Committee on Detection, Evaluation and Treatment of High Blood Pressure (JNC-VI). Arch Intern Med1997; 157: 2413–2446.
12.
ChenBMXiaLWZhaoRQ: Determination of NG, NG-dimethylarginine in human plasma by high performance liquid chromatography. J Chromatogr B Biomed Sci Appl1997; 692: 467–471.
13.
ArakiASakoY: Determination of free and total homocysteine in human plasma by high performance liquid chromatography with fluorescence detection. J Chromatogr1987; 422: 43–52.
14.
AsakawaTMatsushitaS: Coloring conditions of thiobarbituric acid test for detecting lipid hydroperoxides. Lipids1980; 15: 137–140.
15.
HaffnerSMMiettinenHSternMP: The homeostasis model in the San Antonio Heart Study. Diabetes Care1997; 20: 1087–1092.
16.
SchulzeFLenzenHHanefeldC: Asymmetric dimethylarginine is an independent risk factor for coronary heart disease: Results from the multicenter Coronary Artery Risk Determination investigating the Influence of ADMA Concentration (CARDIAC) study. Am Heart J2006; 152: 493.e1–493.e8.
17.
KielsteinJTsikasDFliserD: Effects of asymmetric dimethylarginine (ADMA) infusion in humans. Eur J Clin Pharmacol2006; 62: 39–44.
18.
WangJSimASWangXL: Relation between plasma asymmetric dimethylarginine (ADMA) and risk factors for coronary disease. Atherosclerosis2006; 184: 383–388.
19.
MatsuokaHItohSKimotoM: Asymmetrical dimethylarginine, an endogenous nitric oxide synthase inhibitor, in experimental hypertension. Hypertension1997; 29: 242–247.
20.
KorandjiCZellerMGuillandJC: Asymmetric dimethylarginine (ADMA) and hyperhomocysteinemia in patients with acute myocardial infarction. Clin Biochem2007; 40: 66–72.
21.
BogerRH: Asymmetric dimethylarginine (ADMA) and cardiovascular disease: Insights from prospective clinical trials. Vasc Med2005; 10: S19–S25.
22.
BogerRHLentzSRBogerSM Bode: Elevation of asymmetrical dimethylarginine may mediate endothelial dysfunction during experimental hyperhomocyst(e)inaemia in humans. Clin Sci (Lond)2001; 100: 161–167.
23.
SchmittBWoltersMKresselG: Effects of combined supplementation with B vitamins and antioxidants on plasma levels of asymmetric dimethylarginine (ADMA) in subjects with elevated risk for cardiovascular disease. Atherosclerosis2007; 193: 168–176.
24.
TsioufisCAntoniadisDStefanadisC: Relationships between new risk factors and circadian blood pressure variation in untreated subjects with essential hypertension. Am J Hypertens2002; 15: 600–604.
25.
LedwozywAMichalakJStepienA: The relationship between plasma triglycerides, cholesterol, total lipids and lipid peroxidation products during human atherosclerosis. Clin Chim Acta1986; 155: 275–283.
26.
SrinivasKBhaskarMVKumariRA: Antioxidants, lipid peroxidation, and lipoproteins in primary hypertension. Indian Heart J2000; 52: 285–288.
27.
KananiPMSinkeyCABrowningRL: Role of oxidant stress in endothelial dysfunction produced by experimental hyperhomocyst(e)inemia in humans. Circulation1999; 100: 1161–1168.
28.
SydowKMünzelT: ADMA and oxidative stress. Atherosclerosis2003; 4 (suppl): 41–51.
29.
AsakawaHTokunagaKKamakamiF: Relationship of leptin level with metabolic disorders and hypertension in Japanese type 2 diabetes mellitus. J Diabetes Complications2001; 15: 57–62.
30.
ChanNNChanCN: Asymmetric dimethylarginine (ADMA): A potential link between endothelial dysfunction and cardiovascular diseases in insulin resistance syndrome?Diabetologia2002; 45: 1609–1616.
31.
JuulAScheikeTDavidsenM: Low serum insulin-like growth factor I is associated with increased risk of ischemic heart disease: A population-based case-control study. Circulation2002; 106: 939–944.
